Authors and Affiliates
Elisabeth B Fjelltveit 1,2, Bjørn Blomberg 3,4, Kanika Kuwelker 3,5, Fan Zhou 1, Therese B Onyango 1, Karl A Brokstad 1,6, Rebecca Elyanow 7, Ian M Kaplan 7, Camilla Tøndel 3,8,9, Kristin G I Mohn 1,5, Türküler Özgümüş 10, Rebecca J Cox 1,2, Nina Langeland 3,4, Bergen COVID-19 Research Group;
1 Influenza Centre, Department of Clinical Science, University of Bergen; Bergen, Norway.
2 Department of Microbiology, Haukeland University Hospital; Bergen, Norway.
3 Department of Clinical Science, University of Bergen; Bergen, Norway.
4 National Advisory Unit for Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital; Bergen, Norway.
5 Department of Medicine, Haukeland University Hospital, Bergen, Norway.
6 Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
7 Adaptive Biotechnologies, Seattle, WA, USA.
8 Department of Research and Development, Haukeland University Hospital, Bergen, Norway.
9 Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
10 Department of Global Public Health and Primary Care, University of Bergen; Bergen, Norway.
Authors and Affiliates
Sanghyun P Kim 1, Nolan R Vale 1, Nikolaos Zacharakis 1, Sri Krishna 1, Zhiya Yu 1, Billel Gasmi 2, Jared J Gartner 1, Sivasish Sindiri 1, Parisa Malekzadeh 1, Drew C Deniger 1, Frank J Lowery 1, Maria R Parkhurst 1, Lien T Ngo 1, Satyajit Ray 1, Yong F Li 1, Victoria Hill 1, Maria Florentin 1, Robert V Masi 1, Biman C Paria 1, Noam Levin 1, Alakesh Bera 1, Elizabeth A Hedges 1, Agnes Choi 1, Praveen D Chatani 1, Anup Y Parikh 1, Shoshana Levi 1, Samantha Seitter 1, Yong-Chen Lu 1, Zhili Zheng 1, Todd D Prickett 1, Li Jia 3, Jonathan M Hernandez 4, Chuong D Hoang 5, Paul F Robbins 1, Stephanie L Goff 1, Richard M Sherry 1, James C Yang 1, Steven A Rosenberg 1;
1 Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
2 Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland.
3 National Institutes of Health Library, Office of Director, National Institutes of Health, Bethesda, Maryland.
4 Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
5 Thoracic Surgery Branch, National Cancer Institute, NIH, CCR and The Clinical Center, Bethesda, Maryland.
Authors and Affiliates
Audrey Darmon 1, Ping Zhang 1, Julie Marill 1, Naeemunnisa Mohamed Anesary 1, Jordan Da Silva 1, Sébastien Paris 2;
1 Nanobiotix, Paris, France.
2 Nanobiotix, Paris, France. sebastien.paris@nanobiotix.com.
Authors and Affiliates
Samantha M Fix 1, Marie-Andrée Forget 1, Donastas Sakellariou-Thompson 1, Yunfei Wang 1, Tamara M Griffiths 2, Minjung Lee 3, Cara L Haymaker 3, Ana Lucía Dominguez 1, Rafet Basar 4, Christopher Reyes 5, Sanjay Kumar 5, Larissa A Meyer 6, Patrick Hwu #,7, Chantale Bernatchez #,1, Amir A Jazaeri #,6;
1 Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2 Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
3 Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
4 Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
5 Cell Biology R&D, Thermo Fisher Scientific, Carlsbad, California, USA.
6 Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
7 Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Patrick.Hwu@moffitt.org.
# Contributed equally.
Authors and Affiliates
Mirela Kremenovic 1,2, Alfred A Chan 3, Bing Feng 4, Lukas Bäriswyl 1, Steve Robatel 1,2, Thomas Gruber 1, Li Tang 4, Delphine J Lee 3, Mirjam Schenk 5;
1 Experimental Pathology, University of Bern Institute of Pathology, Bern, Switzerland.
2 Graduate School Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
3 Division of Dermatology, Department of Medicine, The Lundquist Institute, Torrance, California, USA.
4 Institute of Bioengineering and Institute of Materials Science and Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, VD, Switzerland.
5 Experimental Pathology, University of Bern Institute of Pathology, Bern, Switzerland mirjam.schenk@pathology.unibe.ch.
Authors and Affiliates
Nicolas Fernandez 1, Deepak Perumal 2, Adeeb Rahman 3, Seunghee Kim-Schulze 3, Jen Yesil 4, Daniel Auclair 4, Homer Adams 3rd 5, Samir Parekh 6, Sacha Gnjatic 7, Hearn Jay Cho 8;
1 Precision Immunology Institute.
2 Tisch Cancer Institute.
3 Human Immune Monitoring Center.
4 Multiple Myeloma Research Foundation, Norwalk, CT.
5 Janssen Research & Development, LLC, Spring House, PA.
6 Precision Immunology Institute; Tisch Cancer Institute; Department of Oncological Sciences, Icahn School of Medicine at Mt. Sinai, New York, NY.
7 Precision Immunology Institute; Tisch Cancer Institute; Human Immune Monitoring Center.
8 Precision Immunology Institute; Tisch Cancer Institute; Multiple Myeloma Research Foundation, Norwalk, CT. Electronic address: hearn.jay.cho@mssm.edu.
Authors and Affiliates
Thomas Martin,1 Joseph Mikhael,2 Roman Hajek,3 Kihyun Kim,4 Kenshi Suzuki,5 Cyrille Hulin,6 Mamta Garg,7 Hang Quach,8 Hanlon Sia,9 Anup George,10 Tatiana Konstantinova,11 Marie-Laure Risse,12 Gaelle Asset,13 Sandrine Macé,12 Helgi van de Velde,14 and Philippe Moreau15
1Department of Medicine, University of California, San Francisco, CA; 2Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ; 3Department of Hemato-Oncology, University Hospital Ostrava, Faculty of Medicine,
University of Ostrava, Ostrava, Czech Republic; 4Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; 5Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan; 6Department of Hematology, University Hospital Bordeaux, Bordeaux, France; 7Department of Haematology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK; 8Department of Haematology, St Vincent's Hospital, University of Melbourne, Vic, Australia; 9Cancer Care & Haematology Unit, The Tweed Hospital, Tweed Heads, NSW, Australia; 10Wellington Blood and Cancer Center, Wellington, New Zealand; 11Hematology Department, Regional Hospital #1, Ekaterinburg, Russia; 12Sanofi Research and Development, Vitry-Sur-Seine, France; 13Sanofi Research and Development, Chilly-Mazarin, France;
14Sanofi, Cambridge, MA; 15Department of Hematology, University Hospital of Nantes, Nantes, France
Authors and Affiliates
Eleanor Tarantoa, Robert Reddb, Erin Jeterc, Kristin McHughc, Jennifer L. Crombiec, David C. Fisherc,Eric Jacobsenc, Caron A. Jacobsonc, Austin I. Kimc, Ann S. LaCascec, Oreofe O. Odejidec, Parastoo B. Dahid,Yago Nietoe, Robin M. Joycef, Yi-Bin Cheng, Kimberley-Jane C. Bonjoch, Ammar Chaudhryh,Alex F. Herrerah, Philippe Armandc and Reid W. Merrymanc
aDepartment of Medicine, Brigham and Women’s Hospital, Boston, MA, USA; bDepartment of Data Sciences, Dana-Farber CancerInstitute, Boston, MA, USA; cDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA; d
Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; eDepartment of StemCell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; fDepartment of Hematologic Malignancy, Beth Israel Deaconess Medical Center, Boston, MA, USA; gHematopoietic Cell Therapy and Transplant Program, Massachusetts General Hospital, Boston, MA, USA; hDepartment of Hematology and Hematopoietic Cell Transplantation,City of Hope National Medical Center, Duarte, CA, USA
Authors and Affiliates
Susan Bal, MD1,2, Binod Dhakal, MD3, Rebecca W. Silbermann, MD4,Timothy M. Schmidt, MD5, Bhagirathbhai Dholaria, MD6, Smith Giri, MD1,2,Saurabh Chhabra, MD3, Eva Medvedova, MD4, Kelly N. Godby, MD1,2, Anita D'Souza, MD3, Aric C. Hall, MD5, Pamela Hardwick, RN1,2, Jim Omel, MD7, Robert F. Cornell, MD6, Parameswaran Hari, MD3, Natalie S. Callander, MD5, and Luciano J. Costa, MD, PhD1,2
1Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL 2O’Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL 3Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 4Oregon Health & Science University, Portland, OR 5University of Wisconsin, Madison, WI 6Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN 7Independent Patient Advocate, Omaha, NE
Authors and Affiliates
Benjamin A. Derman, MD; Ankit Kansagra, MD; Jeffrey Zonder, MD; Andrew T. Stefka, BS; David L. Grinblatt, MD; Larry D. Anderson Jr, MD, PhD; Sandeep Gurbuxani, MD, PhD; Sunil Narula, MD; Shayan Rayani, MD;Ajay Major, MD; Andrew Kin, MD; Ken Jiang, BS; Theodore Karrison, PhD; Jagoda Jasielec, MD; Andrzej J. Jakubowiak, MD, PhD
University of Chicago Medical Center, Chicago, Illinois (Derman, Stefka, Gurbuxani, Narula, Rayani, Major, Jiang, Karrison, Jasielec, Jakubowiak); Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas (Kansagra, Anderson); Karmanos Cancer Institute, Wayne State University, Detroit, Michigan (Zonder, Kin); NorthShore University Health Systems, Evanston, Illinois (Grinblatt).
